{
    "herf": "http://www.asx.com.au/asx/share-price-research/company/PAR",
    "GICSindustrygroup": "Pharmaceuticals, Biotechnology & Life Sciences",
    "Companyname": "PARADIGM BIOPHARMACEUTICALS LIMITED..",
    "ASXcode": "PAR",
    "data": {
        "summary": {
            "name_short": "PARA BIO",
            "name_full": "PARADIGM BIOPHARMACEUTICALS LIMITED..",
            "code": "PAR",
            "primary_share_code": "PAR",
            "industry_group_name": "Pharmaceuticals, Biotechnology & Life Sciences",
            "delisting_date": null,
            "sector_name": "Health Care",
            "name_abbrev": "PARADIGM BIO.",
            "foreign_exempt": false,
            "listing_date": "2015-08-19T00:00:00+1000",
            "registry_address": "YARRA FALLS, 452 JOHNSTON STREET, ABBOTSFORD, VIC, AUSTRALIA, 3067",
            "recent_announcement": false,
            "investor_relations_email": "kevin@hollingsworthandco.com.au",
            "products": [
                "shares"
            ],
            "phone_number": "(03) 9629 5566",
            "mailing_address": "Level 2, 517 Flinders Lane, MELBOURNE, VIC, AUSTRALIA, 3000",
            "principal_activities": "Biopharmaceutical company focused on repurposing the drug, pentosan polysulphate sodium, for the lead clinical indication of bone marrow edema",
            "fax_number": "(03) 9629 5466",
            "latest_annual_reports": [
                {
                    "header": "Appendix 4E and 2017 Annual Report",
                    "document_date": "2017-08-29T17:33:53+1000",
                    "number_of_pages": 54,
                    "id": "01889756",
                    "market_sensitive": true,
                    "document_release_date": "2017-08-29T17:35:43+1000",
                    "size": "1.0MB",
                    "url": "http://www.asx.com.au/asxpdf/20170829/pdf/43lvmxwxmskdjr.pdf"
                }
            ],
            "primary_share": {
                "volume": 114798,
                "status": [],
                "market_cap": 31365157,
                "code": "PAR",
                "indices": [],
                "deprecated_number_of_shares": 120635219,
                "previous_close_price": 0.26,
                "year_low_date": "2017-06-16T00:00:00+1000",
                "last_trade_date": "2017-12-08T00:00:00+1100",
                "number_of_shares": 120635219,
                "eps": -0.0447,
                "change_in_percent": "0%",
                "change_price": 0.0,
                "pe": 0,
                "offer_price": 0.295,
                "suspended": false,
                "last_price": 0.26,
                "deprecated_market_cap": 31365000,
                "day_low_price": 0.24,
                "open_price": 0.245,
                "year_high_date": "2017-06-14T00:00:00+1000",
                "previous_day_percentage_change": "0%",
                "year_open_date": null,
                "year_high_price": 0.72,
                "bid_price": 0.26,
                "desc_full": "Ordinary Fully Paid",
                "day_high_price": 0.26,
                "average_daily_volume": 202927,
                "year_low_price": 0.23,
                "annual_dividend_yield": 0
            },
            "registry_phone_number": "1300 787 272",
            "web_address": "http://www.paradigmbiopharma.com",
            "fiscal_year_end": "30/06",
            "registry_name": "COMPUTERSHARE INVESTOR SERVICES PTY LIMITED",
            "investor_relations_url": null
        },
        "details": {
            "directors": [
                {
                    "full_name": "Mr Graeme Kaufman",
                    "first_name": "Graeme",
                    "roles": [
                        "Chairman"
                    ],
                    "salutation": "Mr",
                    "last_name": "Kaufman",
                    "middle_name": ""
                },
                {
                    "full_name": "Mr Paul Rennie",
                    "first_name": "Paul",
                    "roles": [
                        "CEO"
                    ],
                    "salutation": "Mr",
                    "last_name": "Rennie",
                    "middle_name": ""
                },
                {
                    "full_name": "Mr Chris Fullerton",
                    "first_name": "Chris",
                    "roles": [
                        "Independent Director"
                    ],
                    "salutation": "Mr",
                    "last_name": "Fullerton",
                    "middle_name": ""
                },
                {
                    "full_name": "Mr John Gaffney",
                    "first_name": "John",
                    "roles": [
                        "Independent Director"
                    ],
                    "salutation": "Mr",
                    "last_name": "Gaffney",
                    "middle_name": ""
                }
            ],
            "secretaries": [
                {
                    "full_name": "Mr Kevin Hollingsworth",
                    "first_name": "Kevin",
                    "roles": [
                        "Company Secretary"
                    ],
                    "salutation": "Mr",
                    "last_name": "Hollingsworth",
                    "middle_name": ""
                }
            ]
        }
    }
}